Behavioral Therapy for Reduction in Smoking Craving
1 other identifier
interventional
40
1 country
1
Brief Summary
The objective of this pilot research is to investigate the effects of two behavioral smoking cessation programs on aspects of cue-induced cigarette craving, and to further investigate the neural bases of such effects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2006
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2006
CompletedFirst Submitted
Initial submission to the registry
March 16, 2007
CompletedFirst Posted
Study publicly available on registry
March 20, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2008
CompletedMay 31, 2017
January 1, 2008
8 months
March 16, 2007
May 26, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Feasibility of recruitment and retention of participants
baseline - session 8 and 6 month follow-up
Participant acceptability of novel behavioral intervention (mindfulness)
baseline - session 8
Secondary Outcomes (17)
Smoking cessation
baseline - session 8 and 6 month follow-up
Exhaled CO readings
baseline, sessions 5 & 8
Salivary cotinine measures
baseline and sessions 5 & 8
Psychological Measures
baseline & session 8
Craving response from a smoking cue (fMRI)
Sessions 1,5, & 8
- +12 more secondary outcomes
Study Arms (2)
1
ACTIVE COMPARATOR2
ACTIVE COMPARATORInterventions
Standard therapy to help participants with smoking cessation.
A novel mind body therapy that extends basic CT principles to include the practice of mindfulness, which fosters a dispassionate approach to the experience of craving.
Eligibility Criteria
You may qualify if:
- Currently be cigarette smokers who desire to quit in the next 30 days (preparation phase).
- Subjects must smoke at least 10 cigarettes per day
- Must be at least 18 years old
- English speaking
- Able to read, understand, and complete a written questionnaire
- Must be willing to attend 8 sessions of behavioral therapy and perform daily home practice
- Must not currently be using pharmacologic therapy to quit
- Must also be willing to abstain from pharmacologic therapy for the duration of the study, which is 8 weeks from the time of enrollment.
- Only strongly right-handed subjects will be included
You may not qualify if:
- Pregnant women
- Have metal permanently in or on the body (aneurysm clips, permanent piercings, permanent dental work)
- Weigh over 300 pounds
- Known problem of claustrophobia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
Related Publications (7)
Astin JA, Shapiro SL, Eisenberg DM, Forys KL. Mind-body medicine: state of the science, implications for practice. J Am Board Fam Pract. 2003 Mar-Apr;16(2):131-47. doi: 10.3122/jabfm.16.2.131.
PMID: 12665179BACKGROUNDBaer RA, Smith GT, Allen KB. Assessment of mindfulness by self-report: the Kentucky inventory of mindfulness skills. Assessment. 2004 Sep;11(3):191-206. doi: 10.1177/1073191104268029.
PMID: 15358875BACKGROUNDBrown KW, Ryan RM. The benefits of being present: mindfulness and its role in psychological well-being. J Pers Soc Psychol. 2003 Apr;84(4):822-48. doi: 10.1037/0022-3514.84.4.822.
PMID: 12703651BACKGROUNDCohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available.
PMID: 6668417BACKGROUNDDavidson RJ, Kabat-Zinn J, Schumacher J, Rosenkranz M, Muller D, Santorelli SF, Urbanowski F, Harrington A, Bonus K, Sheridan JF. Alterations in brain and immune function produced by mindfulness meditation. Psychosom Med. 2003 Jul-Aug;65(4):564-70. doi: 10.1097/01.psy.0000077505.67574.e3.
PMID: 12883106BACKGROUNDGilbert DG, McClernon FJ, Rabinovich NE, Dibb WD, Plath LC, Hiyane S, Jensen RA, Meliska CJ, Estes SL, Gehlbach BA. EEG, physiology, and task-related mood fail to resolve across 31 days of smoking abstinence: relations to depressive traits, nicotine exposure, and dependence. Exp Clin Psychopharmacol. 1999 Nov;7(4):427-43. doi: 10.1037//1064-1297.7.4.427.
PMID: 10609977BACKGROUNDSpeca M, Carlson LE, Goodey E, Angen M. A randomized, wait-list controlled clinical trial: the effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med. 2000 Sep-Oct;62(5):613-22. doi: 10.1097/00006842-200009000-00004.
PMID: 11020090BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hilary A Tindle, MD, MPH
University of Pittsburgh
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 16, 2007
First Posted
March 20, 2007
Study Start
October 1, 2006
Primary Completion
June 1, 2007
Study Completion
May 1, 2008
Last Updated
May 31, 2017
Record last verified: 2008-01